FTC settlement to spark aspirin ads from Bayer

Published on .

Bayer Corp. agreed to launch a $1 million consumer education campaign to settle Federal Trade Commission charges that the company made unsubstantiated claims about the appropriateness of using aspirin for prevention of heart attacks and strokes. Page ads in magazines to run from February through May will promote a phone number to obtain a brochure that says in part "aspirin is not appropriate for everyone." As part of the FTC settlement, Bayer also settled cases with New York and Connecticut attorneys general that included $30,000 payments to both states. In 1985, Bayer's U.S. predecessor agreed to an FTC order barring it from making therapeutic claims without competent and reliable evidence.

Copyright January 2000, Crain Communications Inc.

Most Popular
In this article: